
President Donald Trump on Thursday announced that EMD Serono, a Massachusetts-based healthcare company, will lower the price of Gonal-f, a widely used fertility medication, as part of a broader initiative that includes new federal guidance allowing employers to offer fertility benefits separately from standard health insurance plans.